Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000939767-26-000100
Filing Date
2026-08-05
Accepted
2026-08-05 16:25:50
Documents
17
Effectiveness Date
2026-08-05

Document Format Files

Seq Description Document Type Size
1 S-8 forms-82026.htm S-8 83109
2 EX-5.1 exel-2026formsx8ex5legal.htm EX-5.1 8876
3 EX-23.1 exel202608x2026s-8ex231.htm EX-23.1 2566
4 EX-107 exfilingfees.htm   iXBRL EX-FILING FEES 17610
5 exel-2026formsx8ex5legal001.jpg GRAPHIC 122099
6 exel-2026formsx8ex5legal002.jpg GRAPHIC 221012
7 exel-2026formsx8ex5legal003.jpg GRAPHIC 250414
8 exellogo201709a04a.jpg GRAPHIC 116418
  Complete submission text file 0000939767-26-000100.txt   1210781

Data Files

Seq Description Document Type Size
20 EXTRACTED XBRL INSTANCE DOCUMENT exfilingfees_htm.xml XML 4954
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Filer) CIK: 0000939767 (see all company filings)

EIN.: 043257395 | State of Incorp.: DE | Fiscal Year End: 0101
Type: S-8 | Act: 33 | File No.: 333-298012 | Film No.: 261244025
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)